Screener
USANA Health Sciences USNA Core Nutritional — Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: USANA Health Sciences’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:35 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000896264-26-000034
| Line item | Core Nutritional | Hiya | Rise | Total |
|---|---|---|---|---|
| Net sales (1) | $204,399 | $32,150 | $13,669 | $250,218 |
| Less: | ||||
| Cost of sales | 36,749 | 9,983 | 12,704 | 59,436 |
| Brand Partner incentives | 88,654 | — | — | 88,654 |
| Selling, general and administrative (2) | 60,747 | 24,771 | 2,736 | 88,254 |
| Segment earnings (loss) from operations | $18,249 | $(2,604) | $(1,771) | $13,874 |
| Reconciliation of segment earnings from operations | ||||
| Interest income | 437 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is USANA Health Sciences's core nutritional — net sales?
- USANA Health Sciences (USNA) reported core nutritional — net sales of $204.4M in Q1 2026.
- How has USANA Health Sciences's core nutritional — net sales changed year-over-year?
- USANA Health Sciences's core nutritional — net sales decreased by 3.0% year-over-year, from $210.82M to $204.4M.
- What does core nutritional — net sales mean?
- This represents the total revenue generated from the sale of core nutritional products after accounting for returns, discounts, and allowances. It measures the market demand and sales performance of the company's primary supplement lines. Tracking this figure helps evaluate the growth trajectory and competitive strength of the core product category.
Ask your AI about USANA Health Sciences's core nutritional — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude